On Demand CE - LDL Cholesterol Lowering in Atherosclerotic Cardiovascular Disease

Emerging Insights in LDL Cholesterol Lowering

Lipid specialists Drs. Lynne Braun and Michael Miller discuss the importance of LDL cholesterol management for prevention and management of atherosclerotic cardiovascular disease (ASCVD). The role of non-statin therapies including emerging evidence with PCSK9 inhibition on major CV outcomes is presented in this dynamic presentation.

Supported by an independent educational grant from Agmen, Inc.

Credit: 1.0 CE contact hours, 0.6 pharmacology
Cost: Free

Take this Course

Faculty:

  • Lynne Braun, PhD, CNP, CLS, FAHA, FAAN, FPCNA
  • Michael Miller, MD, FACC, FAHA
Upon completion of this activity, participants will be able to: 
  • Describe how to interpret cholesterol guidelines and identify patient populations with unmet needs
  • on statin therapy.
  • Explain best practices for reducing LDL-C with non-statin therapies.


lipid profile test
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602.